Cargando…

Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson’s Disease?

Parkinson’s disease (PD) is an incurable neurodegenerative disease characterized by aggregation of pathological alpha-synuclein (α-syn) and loss of dopaminergic neuron in the substantia nigra. Inhibition of phosphorylation of the α-syn has been shown to mediate alleviation of PD-related pathology. P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Sijia, Han, Chao, Xia, Yun, Wan, Fang, Hu, Junjie, Kou, Liang, Sun, Yadi, Wu, Jiawei, Li, Yunna, Zhou, Qiulu, Xiong, Nian, Huang, Jinsha, Wang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857133/ https://www.ncbi.nlm.nih.gov/pubmed/34984583 http://dx.doi.org/10.1007/s12035-021-02670-w

Ejemplares similares

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
por: Li, Yunna, et al.
Publicado: (2021)

The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson’s disease via the microglial NLRP3 inflammasome
por: Kou, Liang, et al.
Publicado: (2022)

Calcitriol Alleviates MPP(+)- and MPTP-Induced Parthanatos Through the VDR/PARP1 Pathway in the Model of Parkinson’s Disease
por: Hu, Junjie, et al.
Publicado: (2021)

Investigation on sleep and mental health of patients with Parkinson's disease during the Coronavirus disease 2019 pandemic
por: Xia, Yun, et al.
Publicado: (2020)

Efficacy and safety of 3‐n‐butylphthalide for the treatment of cognitive impairment: A systematic review and meta‐analysis
por: Zhou, Qiulu, et al.
Publicado: (2022)

Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP(+) and MPTP Induced Neurotoxicity: Roles of Nrf2-ARE Signaling Pathway
por: Guo, Xingfang, et al.
Publicado: (2019)

Cluster-Like Headache Secondary to Anamnesis of Sphenoid Ridge Meningioma: A Case Report and Literature Review
por: Kou, Liang, et al.
Publicado: (2019)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
por: Zhang, Guoxin, et al.
Publicado: (2018)

Immune Reconstitution Inflammatory Syndrome Secondary to Autoimmune Hemolytic Anemia and Cryptococcal Meningitis
por: Yin, SiJia, et al.
Publicado: (2019)

Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A
por: Yu, H-C, et al.
Publicado: (2014)

Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): An oncoprotein with many hands
por: De, Pradip, et al.
Publicado: (2014)

Protein interactome of the Cancerous Inhibitor of protein phosphatase 2A (CIP2A) in Th17 cells
por: Khan, Mohd Moin, et al.
Publicado: (2020)

Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer
por: Birkman, Eva‐Maria, et al.
Publicado: (2018)

Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy
por: Chen, Kuen-Feng, et al.
Publicado: (2015)

From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer
por: Chen, Beibei, et al.
Publicado: (2023)

ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells
por: Khanna, Anchit, et al.
Publicado: (2011)

Impulsive and Compulsive Behaviors in Parkinson’s Disease
por: Zhang, Guoxin, et al.
Publicado: (2014)

Excessive Daytime Sleepiness in Parkinson’s Disease
por: Liu, Hanshu, et al.
Publicado: (2022)

The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers
por: Fujiki, Hirota, et al.
Publicado: (2018)

CIP2A expression is increased in prostate cancer
por: Vaarala, Markku H, et al.
Publicado: (2010)

Microglia as modulators of exosomal alpha-synuclein transmission
por: Xia, Yun, et al.
Publicado: (2019)

CIP2A overexpression in Taiwanese oral cancer patients
por: Velmurugan, Bharath Kumar, et al.
Publicado: (2019)

Melatonin ameliorates Parkinson’s disease via regulating microglia polarization in a RORα‐dependent pathway
por: Li, Jingwen, et al.
Publicado: (2022)

Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line
por: Saafan, Hisham, et al.
Publicado: (2021)

Effectiveness of Traditional Chinese Medicine as an Adjunct Therapy for Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Zhang, Guoxin, et al.
Publicado: (2015)

Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer
por: Chen, Wei, et al.
Publicado: (2021)

Prognostic role of CIP2A expression in serous ovarian cancer
por: Böckelman, C, et al.
Publicado: (2011)

Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
por: Liu, Xuewen, et al.
Publicado: (2017)

Genetic Variants in GAPDH Confer Susceptibility to Sporadic Parkinson’s Disease in a Chinese Han Population
por: Liu, Ling, et al.
Publicado: (2015)

The LncRNA DUXAP10 Could Function as a Promising Oncogene in Human Cancer
por: Zhao, Junjie, et al.
Publicado: (2022)

Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cells
por: Zhao, Ming, et al.
Publicado: (2017)

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2011)

Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2009)

Overexpression and Small Molecule-Triggered Downregulation of CIP2A in Lung Cancer
por: Ma, Liang, et al.
Publicado: (2011)

CIP2A Promotes Proliferation of Spermatogonial Progenitor Cells and Spermatogenesis in Mice
por: Ventelä, Sami, et al.
Publicado: (2012)

Reciprocal regulation of CIP2A and AR expression in prostate cancer cells
por: Chuang, Hao-Wen, et al.
Publicado: (2022)

A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects
por: Shen, Yan, et al.
Publicado: (2016)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

Dysregulation of protein phosphatase 2A in parkinson disease and dementia with lewy bodies
por: Park, Hye‐Jin, et al.
Publicado: (2016)

Prognostic significance of CIP2A expression in solid tumors: A meta-analysis
por: Tang, Min, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1fj5meosep7k8s2ndo9124tbup